ID   PLPL8_RAT               Reviewed;         776 AA.
AC   D3ZRC4;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   10-FEB-2021, entry version 88.
DE   RecName: Full=Calcium-independent phospholipase A2-gamma {ECO:0000305};
DE            EC=3.1.1.5 {ECO:0000305|PubMed:15908428};
DE   AltName: Full=Intracellular membrane-associated calcium-independent phospholipase A2 gamma;
DE            Short=iPLA2-gamma;
DE   AltName: Full=Patatin-like phospholipase domain-containing protein 8;
GN   Name=Pnpla8 {ECO:0000312|RGD:1311444};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Li P.W., Adams M.D., Amanatides P.G., Baden-Tillson H.,
RA   Barnstead M., Chin S.H., Dew I., Evans C.A., Ferriera S., Flanigan M.,
RA   Fosler C., Glodek A., Gu Z., Holt R.A., Jennings D., Kraft C.L., Lu F.,
RA   Nguyen T., Nusskern D.R., Pfannkoch C.M., Sitter C., Sutton G.G.,
RA   Venter J.C., Wang Z., Woodage T., Zheng X.H., Zhong F.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15908428; DOI=10.1074/jbc.m502358200;
RA   Yan W., Jenkins C.M., Han X., Mancuso D.J., Sims H.F., Yang K., Gross R.W.;
RT   "The highly selective production of 2-arachidonoyl lysophosphatidylcholine
RT   catalyzed by purified calcium-independent phospholipase A2gamma:
RT   identification of a novel enzymatic mediator for the generation of a key
RT   branch point intermediate in eicosanoid signaling.";
RL   J. Biol. Chem. 280:26669-26679(2005).
CC   -!- FUNCTION: Calcium-independent phospholipase A2, which promotes cellular
CC       membrane hydrolysis and prostaglandin production. Catalyzes the
CC       hydrolysis of the sn-2 position of glycerophospholipids,
CC       phosphytidylserine and to a lower extent phosphatidylcholine. Cleaves
CC       membrane phospholipids. Participates in the generation of lipid second
CC       messengers through the mobilization of arachidonic acid in response to
CC       cellular stimuli. Synthesizes 2-arachidonoyl lysophosphatidylcholine, a
CC       key branch point metabolite in eicosanoid signaling. Participates in
CC       the lipid plasticity of myocardium, plays a role in the generation of
CC       signaling metabolites and has a prominent effect on the modulaton of
CC       energy storage and utilization (By similarity). Essential for
CC       maintaining efficient bioenergetic mitochondrial function through
CC       tailoring mitochondrial membrane lipid metabolism and composition (By
CC       similarity). {ECO:0000250|UniProtKB:Q8K1N1,
CC       ECO:0000250|UniProtKB:Q9NP80}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + H2O = a fatty acid +
CC         H(+) + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:15177,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16870,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:58168; EC=3.1.1.5;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15178;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(9Z,12Z)-octadecadienoyl-sn-glycero-3-
CC         phosphoethanolamine + H2O = (9Z,12Z)-octadecadienoate + a 1-acyl-sn-
CC         glycero-3-phosphoethanolamine + H(+); Xref=Rhea:RHEA:40639,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30245,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:75069;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40640;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(9Z,12Z)-octadecadienoyl-sn-glycero-3-phosphocholine
CC         + H2O = (9Z,12Z)-octadecadienoate + a 1-acyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:40643, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30245, ChEBI:CHEBI:58168,
CC         ChEBI:CHEBI:60000; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40644;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-
CC         phosphoethanolamine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + a 1-
CC         acyl-sn-glycero-3-phosphoethanolamine + H(+); Xref=Rhea:RHEA:40647,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:75067;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40648;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-
CC         phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + a 1-acyl-
CC         sn-glycero-3-phosphocholine + H(+); Xref=Rhea:RHEA:40651,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:58168, ChEBI:CHEBI:75063;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40652;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + H2O = 2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:40571, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:73003, ChEBI:CHEBI:76079;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40572;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(1Z)-hexadecenyl-2 (5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-
CC         glycero-3-phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate +
CC         1-(1Z-hexadecenyl)-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:40579, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73850, ChEBI:CHEBI:77292;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40580;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:40435,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16870, ChEBI:CHEBI:72998;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40436;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-octadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:40819, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:73858,
CC         ChEBI:CHEBI:75034; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40820;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = 2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H(+) +
CC         octadecanoate; Xref=Rhea:RHEA:40823, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25629, ChEBI:CHEBI:75034,
CC         ChEBI:CHEBI:76071; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40824;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-
CC         glycero-3-phosphocholine + H2O = 2-(4Z,7Z,10Z,13Z,16Z,19Z-
CC         docosahexaenoyl)-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41063, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:74963, ChEBI:CHEBI:76085;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41064;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:38779, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73001; Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38780;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphoethanolamine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40431, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73004, ChEBI:CHEBI:73009;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40432;
CC         Evidence={ECO:0000250|UniProtKB:Q9NP80};
CC   -!- ACTIVITY REGULATION: Inhibited by E-6-bromomethylene-3-1-naphthalenyl-
CC       2H-tetrahydropyran-2-one (BEL). {ECO:0000250|UniProtKB:Q9NP80}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q5XTS1}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NP80}. Microsome membrane
CC       {ECO:0000250|UniProtKB:Q5XTS1}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NP80}. Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:Q9NP80}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NP80}. Peroxisome membrane
CC       {ECO:0000305|PubMed:15908428}; Single-pass membrane protein
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC133400; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473947; EDM03350.1; -; Genomic_DNA.
DR   RefSeq; XP_003750198.1; XM_003750150.4.
DR   RefSeq; XP_003754218.1; XM_003754170.4.
DR   SMR; D3ZRC4; -.
DR   IntAct; D3ZRC4; 1.
DR   STRING; 10116.ENSRNOP00000049214; -.
DR   jPOST; D3ZRC4; -.
DR   PeptideAtlas; D3ZRC4; -.
DR   PRIDE; D3ZRC4; -.
DR   Ensembl; ENSRNOT00000047296; ENSRNOP00000049214; ENSRNOG00000039091.
DR   GeneID; 314075; -.
DR   KEGG; rno:314075; -.
DR   CTD; 50640; -.
DR   RGD; 1311444; Pnpla8.
DR   eggNOG; KOG4231; Eukaryota.
DR   GeneTree; ENSGT00940000154738; -.
DR   HOGENOM; CLU_000288_144_7_1; -.
DR   OMA; LFHYTNI; -.
DR   OrthoDB; 1209603at2759; -.
DR   TreeFam; TF319230; -.
DR   Reactome; R-RNO-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-RNO-1482839; Acyl chain remodelling of PE.
DR   PRO; PR:D3ZRC4; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Proteomes; UP000234681; Chromosome 6.
DR   Proteomes; UP000234681; Unassembled WGS sequence.
DR   Bgee; ENSRNOG00000039091; Expressed in quadriceps femoris and 20 other tissues.
DR   ExpressionAtlas; D3ZRC4; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; ISO:RGD.
DR   GO; GO:0005777; C:peroxisome; ISS:UniProtKB.
DR   GO; GO:0047499; F:calcium-independent phospholipase A2 activity; ISS:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102545; F:phosphatidyl phospholipase B activity; IEA:UniProtKB-EC.
DR   GO; GO:0004620; F:phospholipase activity; IBA:GO_Central.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; ISO:RGD.
DR   GO; GO:0050482; P:arachidonic acid secretion; ISO:RGD.
DR   GO; GO:0008219; P:cell death; ISO:RGD.
DR   GO; GO:0006631; P:fatty acid metabolic process; ISO:RGD.
DR   GO; GO:0043651; P:linoleic acid metabolic process; ISO:RGD.
DR   GO; GO:0055088; P:lipid homeostasis; ISS:UniProtKB.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; ISO:RGD.
DR   GO; GO:0046338; P:phosphatidylethanolamine catabolic process; ISO:RGD.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; ISO:RGD.
DR   GO; GO:0070328; P:triglyceride homeostasis; ISS:UniProtKB.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR002641; PNPLA_dom.
DR   Pfam; PF01734; Patatin; 1.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   PROSITE; PS51635; PNPLA; 1.
PE   3: Inferred from homology;
KW   Endoplasmic reticulum; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Membrane; Microsome; Mitochondrion; Peroxisome; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..776
FT                   /note="Calcium-independent phospholipase A2-gamma"
FT                   /id="PRO_0000450242"
FT   TRANSMEM        469..489
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          439..634
FT                   /note="PNPLA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           443..448
FT                   /note="GXGXXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           475..479
FT                   /note="GXSXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           621..623
FT                   /note="DGA/G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   ACT_SITE        477
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   ACT_SITE        621
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOD_RES         730
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K1N1"
SQ   SEQUENCE   776 AA;  87961 MW;  96808D538E5B8B27 CRC64;
     MSINLTLDIY IYFLNNARSF CGKQRSKQLN FLCSKQYWRM NHVNVHREFH TSKKSCKWNR
     SEAHCSKHWH SSSNHGVHIG IVKLSTSAPK GLTKVSIHMS RIKSTLNSVS KAIFGSQNEM
     VSRLAQFKPS SRIFRKVSDR GWLKHKNVKQ AIESLKNYSD KSAEKNSFAE QKSYFADKEE
     GSDKHSLYHY AYRITTRFGE SFYFLANHIN SYFKNKEKMS QIKEDRQLQD KPCLEESKSI
     SPSPDILTDR PDSGPPLNVE DKLSSSTQLP EALPVSTKQS IANFLSRPTE GVQALVGGYI
     GGLVPKLKSD PKSQPEEEEE PSKTDEPICK DKKAEEKKRV LLQREKIIAR VSIDNRTRAL
     VQALRRTTDP KLCITRVEEL TFHLLEFPEG KGVAVKEKII PYLLRLRQIK DETLQAAVRE
     ILALIGYVDP VKGRGIRILA IDGGGTRGVV ALQTLRKLVE LTQKPIHQLF DYICGVSTGA
     ILAFMLGLFH MPLDECEELY RKLGSDVFTQ NVIVGTVKMS WSHAFYDSHT WEKILKDKVG
     SALMIETARD PLCPKVAAVS TIVNRGQTPK AFVFRNYGHF PGTNSHYLGG CQYKMWQAIR
     ASSAAPGYFA EYALGNDLHQ DGGLLLNNPS ALALHECKCI WPDTPLECIV SLGTGRYESD
     VRNTTTYTSL KTKLSNVISS ATDTEEVHIM LDGLLPADTY FRFNPVICEN IPLDESRNEK
     LDQLQLEGMK YLERNDEKMK KLAKILSREK TTLQKISDWI KLKSDMYEGL PFFSKL
//
